Table 5.

Hypothesis testing.

	Performance health			Risks			Issues			All
	rho	p	CI (95%)	rho	p	CI (95%)	rho	p	CI (95%)	rho	p	CI (95%)
HLS-EU-Q16	0.37	<0.001	[0.28, 0.46]	0.50	<0.001	[0.42, 0.57]	0.45	<0.001	[0.37, 0.53]	0.54	<0.001	[0.46, 0.61]
MPIIQM
Interference	−0.16	0.038	[−0.32, −0.00]	−0.16	0.042	[−0.31, 0.00]	−0.15	0.067	[−0.30, 0.02]	−0.20	0.013	[−0.35, −0.04]
Intensity	−0.10	0.215	[−0.26, 0.06]	−0.16	0.051	[−0.31, 0.01]	−0.14	0.082	[−0.29, 0.02]	−0.16	0.045	[−0.31, 0.00]
RAND
Physical	0.08	0.114	[−0.02, 0.17]	0.23	<0.001	[0.14, 0.32]	0.17	<0.001	[0.08, 0.26]	0.21	<0.001	[0.12, 0.30]
Mental	0.18	<0.001	[0.09, 0.27]	0.26	<0.001	[0.16, 0.34]	0.24	<0.001	[0.15, 0.33]	0.29	<0.001	[0.19, 0.37]
GSE	0.17	<0.001	[0.07, 0.26]	0.19	<0.001	[0.10, 0.29]	0.20	<0.001	[0.10, 0.29]	0.22	<0.001	[0.12, 0.31]